DALS

DA32 Life Science Tech Acquisition Corp. [DALS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

DALS Stock Summary

In the News

DALS Financial details

Company Rating
-
Market Cap
264.2M
Income
1.87M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
120.34
Forward P/E
-
PEG
-3.73
P/S
-
P/B
1.33
P/C
-
P/FCF
-363.27
Quick Ratio
0.22
Current Ratio
0.36
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.05
EPS next Y
-
EPS next Q
-
EPS this Y
-236.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
200%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.68-11.22
52W High
-
52W Low
-
RSI
-
Rel Volume
0.08
Avg Volume
29.06K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0.01%, 0.01%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
TSLA
0YXG.L
ABEC.DE
LLY.SW
3V64.DE
Same Sector
OPBK
UTLG.L
MBC.DE
603093.SS
185680.KS
Check Those
NVFY
MOXC
0689.HK
300274.SZ
600311.SS
Similar Market Cap
PSTL
MPC.TO
X014.DE
0311.HK
2086.HK

Company Profile

Financial Services Shell Companies
  • Volume Average 29.06K
  • Market Capitalization 264.2M
  • CEO Dr. Steven Kafka Ph.D.
  • Headquarters New York,NY,US
  • IPO Date 2021-07-28

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.